Dermatol. praxi. 2023;17(4):205-208 [Onkologie. 2023:17(2):127-130]

Hidradenocarcinoma arising in the axilla - a report of a rare case

MUDr. PhDr. Vladimír Bartoš, PhD., MPH1, MUDr. Zuzana Murárová, PhD.2
1 Martinské bioptické centrum, s. r. o., Martin
2 Kožná ambulancia, Národný onkologický ústav, Bratislava

Introduction: Hidradenocarcinoma is a rare malignant adnexal tumor which arises from the intradermal ducts of sweat glands. It often clinically mimics a benign (non-neoplastic) skin disease, which contributes to delayed diagnosis. 



Case report: A 51-year old man had noticed an „inflamed lump“ in his right armpit for the last year. The lesion clinically appeared as a suppurative hidradenitis. After its surgical incision, it was seen a progression of cutaneous tumorous resistance at a given location. The mass was completely excised. Histopathology revealed a solid high-grade carcinoma with a histomorphology and immunophenotype favoring the diagnosis of hidradenocarcinoma. The patient subsequently underwent a wide local reexcision with no tumor residues in the tissue. Further clinical examinations did not confirm tumor recurrence or metastases. 



Conclusion: Cutaneous hidradenocarcinoma is considered to be a neoplasm which exhibits an aggressive biological behaviour. Due to its rarity, it represents the diagnostic and therapeutic challenges in oncodermatological practice. Early detection and complete surgical resection of the tumor with wide surgical margins are critical for further prognosis. The patients must be closely followed up. 

Keywords: hidradenocarcinoma, hidradenoma, skin adnexal tumors.

Published: November 21, 2023  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Bartoš V, Murárová Z. Hidradenocarcinoma arising in the axilla - a report of a rare case. Dermatol. praxi. 2023;17(4):205-208.
Download citation

References

  1. Adamicová K, Fetisovová Ž, Mellová Y, et al. Diagnostika adnexálnych tumorov kože. Čes-slov Patol. 2006;42(2):42-51.
  2. Soni A, Bansal N, Kaushal V, et al. Current management approach to hidradenocarcinoma: a comprehensive review of the literature. Ecancermedicalscience. 2015;9:517. Go to original source... Go to PubMed...
  3. Gao T, Pan S, Li M, et al. Prognostic analysis of hidradenocarcinoma: a SEER-based observational study. Ann Med. 2022;54(1):454-463. Go to original source... Go to PubMed...
  4. Gauerke S, Driscoll JJ. Hidradenocarcinomas: a brief review and future directions. Arch Pathol Lab Med. 2010;134(5):781-785. Go to original source... Go to PubMed...
  5. Kazakov DV, Ivan D, Kutzner H, et al. Cutaneous hidradenocarcinoma: a clinicopathological, immunohistochemical, and molecular biologic study of 14 cases, including Her2/neu gene expression/amplification, TP53 gene mutation analysis, and t(11;19) translocation. Am J Dermatopathol. 2009;31(3):236-247. Go to original source... Go to PubMed...
  6. Cardoso JC, Calonje E. Malignant sweat gland tumours: an update. Histopathology. 2015;67(5):589-606. Go to original source... Go to PubMed...
  7. Nazarian RM, Kapur P, Rakheja D, et al. Atypical and malignant hidradenomas: a histological and immunohistochemical study. Mod Pathol. 2009;22(4):600-610. Go to original source... Go to PubMed...
  8. Płachta I, Kleibert M, Czarnecka AM, et al. Current diagnosis and treatment options for cutaneous adnexal neoplasms with apocrine and eccrine differentiation. Int J Mol Sci. 2021;22(10):5077. Go to original source... Go to PubMed...
  9. Divišová B, Cetkovská P, Pizinger P. Nejčastejší maligní epitelové kožní nádory. Onkologie. 2010;4(4):230-232.
  10. Liapakis IE, Korkolis DP, Koutsoumbi A, et al. Malignant hidradenoma: A report of two cases and review of the literature. Anticancer Res. 2006;26(3B):2217-2220.
  11. Singal R, Garg LN, Pande P, et al. Giant axillary swelling along with multiple ulcers: Primary malignant adnexal tumor - a rare distinct clinicopathologic entity. J Cancer Research Therapeutics. 2011;7(3):379-381. Go to original source... Go to PubMed...
  12. Pandey P, Dixit A, Chandra S, et al. Cytological features of malignant eccrine acrospiroma presenting as a soft tissue mass axilla: A rare sweat gland tumor with histologic correlation. Int J App Basic Med Res. 2015;5(2):145-148. Go to original source... Go to PubMed...
  13. Johnson EP, Keyes J, Zayat V, et al. Malignant hidradenocarcinoma of the axilla. Cureus. 2020;12(2):e7091. Go to original source... Go to PubMed...
  14. Moore JA, Cui S, Berger N, et al. Hidradenocarcinoma: a rare but challenging diagnosis. Clin Imaging. 2021;75:138-142. Go to original source... Go to PubMed...
  15. Williams A, Clemen B, Iyer RI, et al. Rarely seen accelerated progression of hidradenitis suppurativa. J Clin Images Med Case Rep. 2021;2(3):1129. Go to original source...




Dermatology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.